SCHEMBL6974870

SCHEMBL6974870

S=C1[CH]CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7738671 1.00
SCHEMBL5695351 1.00
SCHEMBL7739600 1.00
SCHEMBL66146 0.97
SCHEMBL602295 0.88
SCHEMBL9170284 0.72
SCHEMBL18931046 0.72 ALDH1A1 (0.39)
SCHEMBL6347518 0.65 ALDH1A1 (0.42)
SCHEMBL6584212 0.65
SCHEMBL7738645 0.65 ALDH1A1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109535146-A Antitubercular compounds and its preparation method and application 中国医学科学院医药生物技术研究所 2019-03-29 CN claimed
CN-108884049-A 2 inhibitor of quinolinone lysyloxidase sample and application thereof 法玛克亚公司 2018-11-23 CN claimed
EP-4393924-A1 IMIDAZO [1,2-A] PYRAZINE OR PYRAZOLO [1,5-A] PYRIMIDINE DERIVATIVE AND USE THEREOF Tencent Technology (Shenzhen) Company Limited (CN) 2024-07-03 EP disclosed
CN-118005627-A C-terminal SRC kinase inhibitors 益方生物科技(上海)股份有限公司 2024-05-10 CN disclosed
CN-113166136-B C-terminal SRC kinase inhibitors 益方生物科技(上海)股份有限公司 2024-03-01 CN disclosed
US-20230399332-A1 IMIDAZO[1,2-a]PYRAZINE OR PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND USE THEREOF TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED (CN) 2023-12-14 US disclosed
CN-116421598-A Methods for treating AML-MRC and MDS 苏州亚盛药业有限公司 2023-07-14 CN disclosed
US-20230159463-A1 BENZONITRIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI ZHONGZE THERAPEUTICS, CO. LTD. (CN) 2023-05-25 US disclosed
EP-4137483-A1 BENZONITRIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Zhongze Therapeutics, Co. Ltd. (CN) 2023-02-22 EP disclosed
US-20220305074-A1 PEPTIDE AMIDE COMPOSITION AND PREPARATION METHOD THEREFOR SICHUAN HAISCO PHARMACEUTICAL CO., LTD. (CN) 2022-09-29 US disclosed
EP-4019033-A1 PEPTIDE AMIDE COMPOSITION AND PREPARATION METHOD THEREFOR Sichuan Haisco Pharmaceutical Co., Ltd. (CN) 2022-06-29 EP disclosed
CN-107108562-A With β2Nitrogen-containing heterocyclic ring derivative with receptor agonistic and M receptor antagonistic activities and application thereof in medicine 四川海思科制药有限公司 2017-08-29 CN disclosed
CN-107108502-A having beta2Biphenyl derivatives with receptor agonism and M receptor antagonistic activity and application thereof in medicine 四川海思科制药有限公司 2017-08-29 CN disclosed
CN-107074833-A With β2The Benzocyclodirivative of receptor agonism and M3 receptor antagonist activities and its in purposes pharmaceutically 四川海思科制药有限公司 2017-08-18 CN disclosed
EP-1200428-B1 SUBSTITUTED BENZOXAZOLES BASF AG (DE) 2003-04-16 EP disclosed
US-6410748-B1 Alicycli c group-containing monomer KABUSHIKI KAISHA TOSHIBA (JP) 2002-06-25 US disclosed
EP-1200428-A1 SUBSTITUTED BENZOXAZOLES BASF AKTIENGESELLSCHAFT (DE) 2002-05-02 EP disclosed
US-6291129-B1 LIGHT SENSITIVE ELEMENT WITH UNSATURATED POLYMERS KABUSHIKI KAISHA TOSHIBA (JP) 2001-09-18 US disclosed
WO-2001012625-A2 SUBSTITUTED BENZOXAZOLES BASF AKTIENGESELLSCHAFT (DE) 2001-02-22 WO disclosed
CN-1244865-A Substituted pyrazole-3-yl benzazoles BASF AK (DE) 2000-02-16 CN disclosed